Guo HY - Search Results

1

Vinorelbine and capecitabine in anthracycline- and/or taxane-pretreated metastatic breast cancer: sequential or combinational?

Zhang J, Gu SY, Gan Y, Wang ZH, Wang BY, Guo HY, Wang JL, Wang LP, Zhao XM, Hu XC. Zhang J, et al. Among authors: guo hy. Cancer Chemother Pharmacol. 2013 Jan;71(1):103-13. doi: 10.1007/s00280-012-1983-y. Epub 2012 Oct 2. Cancer Chemother Pharmacol. 2013. PMID: 23053266 Clinical Trial.

2

Primary non-Hodgkin's lymphoma of the breast: eight-year follow-up experience.

Guo HY, Zhao XM, Li J, Hu XC. Guo HY, et al. Int J Hematol. 2008 Jun;87(5):491-497. doi: 10.1007/s12185-008-0085-4. Epub 2008 Apr 15. Int J Hematol. 2008. PMID: 18414980

3

[Prognosis of primary non-Hodgkin's lymphoma of the breast].

Guo HY, Zhao XM, Cao JN, Hu XC, Yin JL, Hong XN, Li J. Guo HY, et al. Zhonghua Zhong Liu Za Zhi. 2008 Mar;30(3):200-2. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 18756936 Chinese.

4

Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potential clinical significance.

Zhao X, Xu X, Guo L, Ragaz J, Guo H, Wu J, Shao Z, Zhu J, Guo X, Chen J, Zhu B, Wang Z, Hu X. Zhao X, et al. Breast Cancer Res Treat. 2010 Dec;124(3):733-43. doi: 10.1007/s10549-010-1183-6. Epub 2010 Sep 30. Breast Cancer Res Treat. 2010. PMID: 20882405 Clinical Trial.

5

Safety and pharmacokinetics of novel selective vascular endothelial growth factor receptor-2 inhibitor YN968D1 in patients with advanced malignancies.

Li J, Zhao X, Chen L, Guo H, Lv F, Jia K, Yv K, Wang F, Li C, Qian J, Zheng C, Zuo Y. Li J, et al. BMC Cancer. 2010 Oct 5;10:529. doi: 10.1186/1471-2407-10-529. BMC Cancer. 2010. PMID: 20923544 Free PMC article. Clinical Trial.

6

PI3K pathway activation results in low efficacy of both trastuzumab and lapatinib.

Wang L, Zhang Q, Zhang J, Sun S, Guo H, Jia Z, Wang B, Shao Z, Wang Z, Hu X. Wang L, et al. BMC Cancer. 2011 Jun 15;11:248. doi: 10.1186/1471-2407-11-248. BMC Cancer. 2011. PMID: 21676217 Free PMC article. Clinical Trial.

7

S-1 monotherapy as second line chemotherapy in advanced gastric cancer patients previously treated with cisplatin/infusional fluorouracil.

Lv F, Liu X, Wang B, Guo H, Li J, Shen L, Jin M. Lv F, et al. Int J Clin Exp Pathol. 2014 May 15;7(6):3293-8. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25031751 Free PMC article. Clinical Trial.

8

S-1 monotherapy as second line chemotherapy in advanced gastric cancer patients previously treated with cisplatin/infusional fluorouracil.

Lv F, Liu X, Wang B, Guo H, Li J, Shen L, Jin M. Lv F, et al. Int J Clin Exp Pathol. 2014 Jun 15;7(7):4274-9. eCollection 2014. Int J Clin Exp Pathol. 2014. Retraction in: Int J Clin Exp Pathol. 2016 Feb 01;9(2):2755. PMID: 25120809 Free PMC article. Retracted. Clinical Trial.

9

A Phase I study of KH901, a conditionally replicating granulocyte-macrophage colony-stimulating factor: armed oncolytic adenovirus for the treatment of head and neck cancers.

Chang J, Zhao X, Wu X, Guo Y, Guo H, Cao J, Guo Y, Lou D, Yu D, Li J. Chang J, et al. Cancer Biol Ther. 2009 Apr;8(8):676-82. doi: 10.4161/cbt.8.8.7913. Epub 2009 Apr 22. Cancer Biol Ther. 2009. PMID: 19242097 Free article. Clinical Trial.

10

YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivo.

Tian S, Quan H, Xie C, Guo H, Lü F, Xu Y, Li J, Lou L. Tian S, et al. Cancer Sci. 2011 Jul;102(7):1374-80. doi: 10.1111/j.1349-7006.2011.01939.x. Epub 2011 May 9. Cancer Sci. 2011. PMID: 21443688 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

484 results

Search Page

Filters